Hailey N Miller1, Miriam B Berger2, Sandy Askew2, Melissa C Kay2, Christina M Hopkins3, Meghana Sai Iragavarapu2, Mia de Leon2, Megan Freed4, Cherie N Barnes4, Qing Yang5, Crystal C Tyson6, Laura P Svetkey6, Gary G Bennett3, Dori M Steinberg7. 1. School of Nursing, Duke University, Durham, NC, United States of America; Duke Global Digital Health Science Center, Duke University, Durham, NC, United States of America. Electronic address: hm189@duke.edu. 2. Duke Global Digital Health Science Center, Duke University, Durham, NC, United States of America. 3. Duke Global Digital Health Science Center, Duke University, Durham, NC, United States of America; Department of Psychology and Neuroscience, Duke University, Durham, NC, United States of America. 4. School of Nursing, Duke University, Durham, NC, United States of America; Duke Global Digital Health Science Center, Duke University, Durham, NC, United States of America. 5. School of Nursing, Duke University, Durham, NC, United States of America. 6. School of Medicine, Duke University, Durham, NC, United States of America. 7. School of Nursing, Duke University, Durham, NC, United States of America; Equip Health, LLC, San Diego, CA, United States of America.
Abstract
INTRODUCTION: Over 100 million adults in the United States have hypertension. The DASH (Dietary Approaches to Stop Hypertension) eating pattern is an evidence-based first-line treatment option for hypertension; however, adherence to the DASH eating pattern at a population level remains low. To address this gap, we will implement Nourish, a randomized controlled efficacy trial that will leverage a commercially-available smartphone application and evidence-based behavior change principles to improve adherence to the DASH eating pattern among adults with hypertension. METHODS: The Nourish trial is a two-arm, 12-month randomized control trial that will enroll adults (N = 300) with hypertension, defined as a systolic blood pressure of 120-159 mmHg; a diastolic blood pressure of 80-99 mmHg; and/or adults on blood pressure-lowering medication. Nourish will test the efficacy of a digital health intervention, as compared to the attention control arm, on DASH eating pattern adherence and blood pressure. Intervention components will include skills training, self-monitoring, personalized feedback, and responsive coaching. The primary outcome of the trial is 6-month changes in adherence to the DASH eating pattern, as measured by 24-h dietary recalls. DISCUSSION: Millions of Americans remain in need of effective behavioral interventions to manage and improve their hypertension and its adverse consequences. The ubiquity of smartphones offers a promising approach to disseminate the DASH eating pattern. By leveraging these widely used smartphone applications, combined with evidence-based behavior change principles and the DASH eating plan, Nourish will demonstrate the effectiveness of a digital health intervention to improve DASH adherence, and ultimately, to reduce blood pressure. Trial Number: NCT03875.
INTRODUCTION: Over 100 million adults in the United States have hypertension. The DASH (Dietary Approaches to Stop Hypertension) eating pattern is an evidence-based first-line treatment option for hypertension; however, adherence to the DASH eating pattern at a population level remains low. To address this gap, we will implement Nourish, a randomized controlled efficacy trial that will leverage a commercially-available smartphone application and evidence-based behavior change principles to improve adherence to the DASH eating pattern among adults with hypertension. METHODS: The Nourish trial is a two-arm, 12-month randomized control trial that will enroll adults (N = 300) with hypertension, defined as a systolic blood pressure of 120-159 mmHg; a diastolic blood pressure of 80-99 mmHg; and/or adults on blood pressure-lowering medication. Nourish will test the efficacy of a digital health intervention, as compared to the attention control arm, on DASH eating pattern adherence and blood pressure. Intervention components will include skills training, self-monitoring, personalized feedback, and responsive coaching. The primary outcome of the trial is 6-month changes in adherence to the DASH eating pattern, as measured by 24-h dietary recalls. DISCUSSION: Millions of Americans remain in need of effective behavioral interventions to manage and improve their hypertension and its adverse consequences. The ubiquity of smartphones offers a promising approach to disseminate the DASH eating pattern. By leveraging these widely used smartphone applications, combined with evidence-based behavior change principles and the DASH eating plan, Nourish will demonstrate the effectiveness of a digital health intervention to improve DASH adherence, and ultimately, to reduce blood pressure. Trial Number: NCT03875.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Jinnie J Rhee; Laura Sampson; Eunyoung Cho; Michael D Hughes; Frank B Hu; Walter C Willett Journal: Am J Epidemiol Date: 2015-02-05 Impact factor: 4.897
Authors: Hailey N Miller; Jeanne Charleston; Beiwen Wu; Kelly Gleason; Karen White; Cheryl R Dennison Himmelfarb; Daniel E Ford; Timothy B Plante; Allan C Gelber; Lawrence J Appel; Edgar R Miller; Stephen P Juraschek Journal: Clin Trials Date: 2020-09-15 Impact factor: 2.486
Authors: Hailey N Miller; Miriam B Berger; Sandy Askew; Elizabeth Trefney; Crystal Tyson; Laura Svetkey; Gary G Bennett; Dori M Steinberg Journal: J Cardiovasc Nurs Date: 2022-04-23 Impact factor: 2.468
Authors: Hailey N Miller; Corrine I Voils; Kate A Cronin; Elizabeth Jeanes; Jeffrey Hawley; Laura S Porter; Rachel R Adler; Whitney Sharp; Samantha Pabich; Kara L Gavin; Megan A Lewis; Heather M Johnson; William S Yancy; Kristen E Gray; Ryan J Shaw Journal: JMIR Form Res Date: 2022-09-06